Bio-Connect
WB analysis of mouse pancreas tissue lysate using GTX54049 Hrk antibody at (A) 2.5 and (B) 5ug/ml.
WB analysis of mouse pancreas tissue lysate using GTX54049 Hrk antibody at (A) 2.5 and (B) 5ug/ml.
WB analysis of mouse pancreas tissue lysate using GTX54049 Hrk antibody at (A) 2.5 and (B) 5ug/ml.

Hrk antibody

GTX54049
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetHRK
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Hrk antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 2-5microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID8739
  • Target name
    HRK
  • Target description
    harakiri, BCL2 interacting protein
  • Target synonyms
    DP5, HARAKIRI, activator of apoptosis harakiri, BH3-interacting domain-containing protein 3, activator of apoptosis Hrk, death protein 5, harakiri, BCL2 interacting protein (contains only BH3 domain), neuronal death protein DP5
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDO00198
  • Protein Name
    Activator of apoptosis harakiri
  • Scientific Description
    This gene encodes a member of the BCL-2 protein family. Members of this family are involved in activating or inhibiting apoptosis. The encoded protein localizes to intracellular membranes. This protein promotes apoptosis by interacting with the apoptotic inhibitors BCL-2 and BCL-X(L) via its BH3 domain. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    41116161

References

  • HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer. Dong Z et al., 2018 Jan 2, Oncotarget
    Read this paper